Arizona sophomore guard Allonzo Trier hasn't played a game yet this season, and the reason for his absence, according to a report Wednesday night from ESPN's Jeff Goodman, is a failed drug test in September. Trier appealed the NCAA's decision and won the appeal; the NCAA still won't let him compete until the drug is completely out of his system. He cannot be cleared to play until the drug completely leaves his system, according to Jeff Goodman of ESPN. Others have stepped up in his absence though, and Arizona is 16-2 and 5-0 in the Pac-12 heading into road games this week at USC and UCLA.
Last season as a freshman, Trier averaged 14.8 points and 3.3 rebounds per game.
Since September the young star has been tested multiple times to see if the drug is still lingering in his system.
Mercedes' newest addition - Valtteri Bottas
Deputy team principal Claire Williams stated that it was important for the team to bring in a "strong" replacement for Bottas. For Bottas the move up to Mercedes , who have dominated for the last three years, represents the opportunity of a lifetime .
Arizona Wildcats guard Allonzo Trier hasn't been allowed to play this season, and no one is saying why. Trier, arguably the most talented guard on Arizona's loaded roster, has been relegated to the bench, where he's become the team's most vocal and visible cheerleader; for three months, nobody knew why.
Earlier this season, I was notified that I tested positive for a trace amount of a banned performance-enhancing drug following an NCAA random test and I was shocked.
This has been a season-long saga for the Wildcats that started when Trier was mysteriously pulled out of media day. He has been allowed to practice and travel with the team. As soon as the test come back clear, Trier will be able to play and provide another scorer for the Wildcats. It will also give the Wildcats another outlet that they can go to late in a game or shot clock. All they can do is wait, and wait, and wait, and hope that their best player returns in time for March.